The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Open accessAbstract
Blood biomarkers have been considered tools for the diagnosis, prognosis, and monitoring of Alzheimer's disease (AD). Although amyloid-β peptide (Aβ) and tau are primarily blood biomarkers, recent studies have identified other reliable candidates that can serve as measurable indicators of pathological conditions. One such candidate is the glial fibrillary acidic protein (GFAP), an astrocytic cytoskeletal protein that can be detected in blood samples. Increasing evidence suggests that blood GFAP levels can be used to detect early-stage AD. In this systematic review and meta-analysis, we aimed to evaluate GFAP in peripheral blood as a biomarker for AD and provide an overview of the evidence regarding its utility. Our analysis revealed that the GFAP level in the blood was higher in the Aβ-positive group than in the negative groups, and in individuals with AD or mild cognitive impairment (MCI) compared to the healthy controls. Therefore, we believe that the clinical use of blood GFAP measurements has the potential to accelerate the diagnosis and improve the prognosis of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that plasma GFAP and NfL are elevated not only in FTD but also in other neurological diseases such as Alzheimer disease [7], stroke [50, 51], and TBI [6], these biomarkers are not anticipated to serve as FTD-specific diagnostic markers.”
From Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders (2025) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00616-3 · Cited by 807
A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T., Mulrow, C. D., Shamseer, L., Tetzlaff, J., Akl, E. A., Brennan, S., et al. (2022) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2022.112 · Cited by 761
Flagged first, then by citations
Research works printed but not linked: 2
- Page, 2022, The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsDeclaracion PRISMA 2020: Una guia actualizada para la publicacion de revisiones sistematicas, Rev. Panam. Salud Publica, 46, e112
- Hansen, 2022, Blood Based Biomarker for Optimization of Early and Differential Diagnosis of Alzheimer’s Dementia, Fortschr. Neurol. Psyc, 90, 326
Cited by
Sorted by citations
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease
Schöll, M., Verberk, I. M. W., del Campo, M., Delaby, C., Therriault, J., Chong, J. R., Palmqvist, S., & Alcolea, D. A. (2024) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2024.07.013 · Cited by 150
Jiang, S., Cai, G., Yang, Z., Shi, H., Zeng, H., Ye, Q., Hu, Z., & Wang, Z. (2024) · ACS Nano · doi:10.1021/acsnano.3c13150 · Cited by 135
Chadarevian, J. P., Hasselmann, J., Lahian, A., Capocchi, J. K., Escobar, A., Lim, T. E., Le, L., Tu, C., Nguyen, J., Kiani Shabestari, S., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.023 · Cited by 83
Heneka, M. T., Gauthier, S. G., Chandekar, S. A., Hahn-Pedersen, J. H., Bentsen, M. A., & Zetterberg, H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02939-9 · Cited by 97
Ali, M., Timsina, J., Western, D., Liu, M., Beric, A., Budde, J., Do, A., Heo, G., Wang, L., Gentsch, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.014 · Cited by 61
Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
Dhauria, M., Mondal, R., Deb, S., Shome, G., Chowdhury, D., Sarkar, S., & Benito‐León, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010911 · Cited by 62
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection
Duff, E. P., Zetterberg, H., Heslegrave, A., Dehghan, A., Elliott, P., Allen, N. E., Runz, H., Laban, R., Veleva, E., Whelan, C. D., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03426-4 · Cited by 61
Du, L., Langhough, R. E., Wilson, R. E., Reyes, R. E. R., Hermann, B. P., Jonaitis, E. M., Betthauser, T. J., Chin, N. A., Christian, B., Chaby, L., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14100 · Cited by 46
The impact of physical exercise on neuroinflammation mechanism in Alzheimer’s disease
Hu, J., Huang, B., & Chen, K. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1444716 · Cited by 55
Acoustic Speech Analysis in Alzheimer's Disease: A Systematic Review and Meta-Analysis
Saeedi, S., Hetjens, S., Grimm, M., & Latoszek, B. B. V. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.132 · Cited by 43
Sex Differences in Astrocyte Activity
Gozlan, E., Lewit-Cohen, Y., & Frenkel, D. (2024) · Cells · doi:10.3390/cells13201724 · Cited by 43
Biofluid biomarkers in Alzheimer’s disease and other neurodegenerative dementias
Zetterberg, H., & Bendlin, B. B. (2026) · Nature · doi:10.1038/s41586-025-10018-w · Cited by 45
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Lee, E., & Chang, Y. (2025) · Cells · doi:10.3390/cells14030168 · Cited by 39
Gu, Y., Honig, L. S., Kang, M. S., Bahl, A., Sanchez, D. L., Reyes‐Dumeyer, D., Manly, J. J., Dage, J. L., Lantigua, R., Brickman, A. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13652 · Cited by 33
Bellelli, F., Angioni, D., Arosio, B., Vellas, B. J., & Barreto, P. D. S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102699 · Cited by 34
Edwards, N. C., Lao, P. J., Alshikho, M. J., Ericsson, O. M., Rizvi, B. M., Petersen, M. E., O’Bryant, S. E., Aguilar, L. F., Simoes, S., Mapstone, M. E., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae331 · Cited by 34
Yu, Z., Yang, Y., Chen, X., Wong, K., Zhang, Z., Zhao, Y., & Li, X. (2024) · Advanced Science · doi:10.1002/advs.202410081 · Cited by 30
Zhang, Y., Bi, K., Zhou, L., Wang, J., Huang, L., Sun, Y., Peng, G., & Wu, W. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s471174 · Cited by 30
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03475-z · Cited by 28
Mahjoubi, M. A., Lamrani, D., Saleh, S., Moutaouakil, W., Ouhmida, A., Hamida, S., Cherradi, B., & Raihani, A. (2025) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2025.100219 · Cited by 27
Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches
Prajapati, S. K., Pathak, A., & Samaiya, P. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01389-6 · Cited by 21
Central autonomic network dysfunction and plasma Alzheimer’s disease biomarkers in older adults
Lohman, T., Kapoor, A., Engstrom, A. C., Shenasa, F., Alitin, J. P. M., Gaubert, A., Rodgers, K. E., Bradford, D. R., Mather, M., Han, S. D., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01486-9 · Cited by 26
Hindam, M. O., Ahmed, L. A., Sayed, N. S. E., Khattab, M., & Sallam, N. A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122838 · Cited by 27
Ankul, S. S., Chandran, L., Singh, A., Kaliappan, I., Rushendran, R., & Vellapandian, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1283440 · Cited by 26
Systematic review and meta‐analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue
Heberle, B. A., Fox, K. L., Libermann, L. L., Xavier, S. R. M., Dallarosa, G. T., Santos, R. C., Fardo, D. W., Viola, T. W., & Ebbert, M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70025 · Cited by 30
Zou, Y., Wang, Y., Ma, X., Mu, D., Zhong, J., Ma, C., Mao, C., Yu, S., Gao, J., & Qiu, L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102485 · Cited by 24
Sheth, U., Öijerstedt, L., Heckman, M. G., White, L. J., Heuer, H. W., Lario Lago, A., Forsberg, L. K., Faber, K. M., Foroud, T. M., Rademakers, R., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00821-4 · Cited by 20
SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia
Chatziefstathiou, A., Canaslan, S., Kanata, Ε., Vekrellis, K., Constantinides, V. C., Paraskevas, G. P., Kapaki, E. N., Schmitz, M., Zerr, I., Xanthopoulos, K., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12061253 · Cited by 22
Agnello, L., Gambino, C. M., Ciaccio, A. M., Salemi, G., Brighina, F., Ragonese, P., Piccoli, T., Blandino, V., Stefano, V. D., Cacciabaudo, F., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120248 · Cited by 21
Maschio, V. P. D., Roveta, F., Bonino, L., Boschi, S., Rainero, I., & Rubino, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178564 · Cited by 24
Nam, M.-H., Na, H., Lee, C. J., & Yun, M. (2024) · Nuclear medicine and molecular imaging · doi:10.1007/s13139-023-00837-y · Cited by 21
Li, Y., Luo, L., Senicar, L., Asrosa, R., Kizilates, S. B., Xing, K., Torres, E., Xu, L., Li, D., Graham, N., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401966 · Cited by 20
Mitolo, M., Lombardi, G., Manca, R., Nacmias, B., & Venneri, A. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12674-w · Cited by 20
Sarkar, S., Bhui, U., Kumar, B., Ashique, S., Kumar, P., Sharma, H., Bhowmick, M., Pal, R., & Kumar, T. (2024) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822329981241007105405 · Cited by 25
Recent Advances in Antibody Therapy for Alzheimer’s Disease: Focus on Bispecific Antibodies
Yang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136271 · Cited by 19
Cognitive Performance and Incident Alzheimer's Dementia in Men Versus Women
Liampas, I., Siokas, V., Lyketsos, C. G., & Dardiotis, E. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.90 · Cited by 18
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105724 · Cited by 20
Rabl, M., Zullo, L., Lewczuk, P., Kornhuber, J., Karikari, T. K., Blennow, K., Zetterberg, H., Bavato, F., Quednow, B. B., Seifritz, E., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01526-4 · Cited by 24
Neurodegenerative diseases early detection and monitoring system for point-of-care applications
Thakur, R. R., Saini, A. K., Taliyan, R., & Chaturvedi, N. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.112280 · Cited by 18
Biomarkers of neurodegeneration and neural injury as potential predictors for delirium
Fong, T. G., Vasunilashorn, S. M., Kivisäkk, P., Metzger, E. D., Schmitt, E. M., Marcantonio, E. R., Jones, R. N., Shanes, H., Arnold, S. E., Inouye, S. K., et al. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6044 · Cited by 16
APOE ε4 carrier status modifies plasma p‐tau181 concentrations in cognitively healthy super‐seniors
Cooper, J. G., Ghodsi, M., Stukas, S. K., Leach, S. R., Brooks-Wilson, A. R., & Wellington, C. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13804 · Cited by 16
Villareal, J. A. B., Bathe, T., Hery, G. P., Phillips, J. L., Tsering, W., & Prokop, S. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03196-3 · Cited by 17
The Evaluation of Clinical Applications for the Detection of the Alzheimer’s Disease Biomarker GFAP
Ozcelikay, G., Karadurmuş, L., Çetinkaya, A., Uludağ, İ., Özcan, B., Ünal, M. A., Sezgintürk, M. K., & Özkan, S. A. (2024) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2024.2393874 · Cited by 16
Ianni, M., Corraliza-Gómez, M., Costa-Coelho, T., Ferreira-Manso, M., Inteiro-Oliveira, S., Alemãn-Serrano, N., Sebastião, A. M., Garcia, G., Diógenes, M. J., & Brites, D. M. T. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179475 · Cited by 18
Chen, G., Li, H., Shao, X., Wang, D. J. J., Hu, W., Han, Y., & Yang, Q. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70089 · Cited by 16
Fazeli, B., José, N. G. D. S., Jesse, S., Şenel, M., Oeckl, P., Erhart, D. K., Ludolph, A. C., Otto, M., Halbgebauer, S., & Tumani, H. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-1256 · Cited by 16
Marksteiner, J., & Humpel, C. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100038 · Cited by 16
Beydoun, M. A., Beydoun, H. A., Li, Z., Hu, Y., Hooten, N. N., Ding, J., Hossain, S. A., Vieytes, C. A. M., Launer, L. J., Evans, M. K., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01413-8 · Cited by 15
Mostafa, F., Mantawy, E. M., Said, R. S., Azab, S. S., & El‐Demerdash, E. (2025) · Psychopharmacology · doi:10.1007/s00213-024-06706-6 · Cited by 16
Wawrzyniak, A., Krawczyk-Marć, I., Żuryń, A., Walocha, J. A., & Balawender, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189080 · Cited by 19
Liao, W., Yu, Q., Chen, B., Chen, H., Zou, L., Xie, H., Chen, H., Wang, C., Li, Y., Gao, X., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71231 · Cited by 14
Liampas, I., Dimitriou, N., Siokas, V., Messinis, L., Nasios, G., & Dardiotis, E. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02769-9 · Cited by 18
Shrief, A. I., Elshenawy, D. S. A., Elsukary, A. E., Elekhtiar, S. A., & Yahia, O. A. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10361-2 · Cited by 16
Wu, Y., Shao, Y., Shao, X., Yu, H., Wang, M., Wang, J., She, Y., Liu, J., Zhang, T., Li, Z., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145427 · Cited by 17
Zhao, D., Wang, J., Zhu, Y., Zhang, H., Ni, C., Zhao, Z., Dai, J., He, R., Liu, G.-Z., Gan, C., et al. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00510-8 · Cited by 18
Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
Nehra, G., Maloney, B. J., Smith, R. R., Chumboatong, W., Abner, E. L., Nelson, P. T., Bauer, B., & Hartz, A. M. S. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00615-8 · Cited by 13
Rodda, J. E., Kuchenbecker, L. A., Borelli, W. V., DeMarco, M. L., Castilhos, R. M., Cawston, E. E., Chabrashvili, T., Budelier, M. M., Duran-Aniotz, C. A., Udeh‐Momoh, C. T., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70201 · Cited by 13
Cruchaga, C., Ali, M., Shen, Y., Do, A. N., Wang, L., Western, D., Liu, M., Beric, A., Budde, J., Gentsch, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3631708/v1 · Cited by 14
Blood levels of cytokines highlight the role of inflammation in Alzheimer's disease
Campanelli, L., Galeano, P., Prestia, F. A., Cuesta, C., Dalmasso, M. C., Flores-López, M., Gona, C., Irureta, N., Kairiyama, C., Lisso, J., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41725 · Cited by 16
Bolton, C. J., Rostamzadeh, A., Chin, N. A., Fowler, N. R., Heidebrink, J. L., Rahman‐Filipiak, A., Romano, R. R., & Clark, L. R. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100310 · Cited by 12
Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities
Li, J., Wang, L., Zhang, X., Shi, J., Zhu, Y. Z., Wang, H., Zhu, X., Zhu, Q., & Luo, J. (2025) · Biomolecules · doi:10.3390/biom15091290 · Cited by 13
Mir, P. A., Kumar, N. G., Bhutia, G. T., Chaudhary, P., Kaur, G., & Gupta, S. K. (2026) · GeroScience · doi:10.1007/s11357-025-02062-1 · Cited by 13
Zhang, M., Chen, H., Huang, W., Guo, T., Ma, G., Han, Y., & Shu, N. (2024) · Human Brain Mapping · doi:10.1002/hbm.26566 · Cited by 11
Assessing polyomic risk to predict Alzheimer's disease using a machine learning model
Ngai, T., Willett, J., Waqas, M., Fishbein, L., Choi, Y., Hahn, G., Mullin, K., Lange, C., Hecker, J., Tanzi, R. E., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14319 · Cited by 12
Wang, J. D. J., Leow, Y. J., Vipin, A., Sandhu, G. K., & Kandiah, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083541 · Cited by 12
McInvale, J. J., Canoll, P., & Hargus, G. (2024) · Brain Pathology · doi:10.1111/bpa.13231 · Cited by 11
Milos, T., Vuić, B., Balic, N., Farkaš, V., Erjavec, G. N., Štrac, D. Š., Perković, M. N., & Pivac, N. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2400683 · Cited by 11
Defining Alzheimer’s Disease through Proteomic CSF Profiling
Peña‐Bautista, C., Álvarez‐Sánchez, L., Balaguer, Á., Raga, L., García, L., Baquero, M., & Cháfer‐Pericás, C. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00590 · Cited by 13
Ghanbarian, E., Qian, T., Khorsand, B., Zheng, L., Sajjadi, S. A., Grill, J. D., Rabin, L. A., Lipton, R. B., Sperling, R. A., & Ezzati, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70948 · Cited by 10
Weerakkody, T. N., Sabelström, H., Andrews, S. V., Chadarevian, J. P., Chin, M. Y., Tatarakis, D., Propson, N. E., Kim, D. J., Theolis, R., Parico, G. C. G., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adw7428 · Cited by 12
Biomarkers in Alzheimer's disease clinical trials: 2025
Osse, A. M. L., Zhou, Y., Kinney, J. W., Hooyman, A., Sengupta, A., Fonseca, J., Burstein, A. H., Owen, M., Nisenbaum, L., Fillit, H. M., et al. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70217 · Cited by 12
Lahiri, D. K., Maloney, B., Wang, R., White, F. A., Sambamurti, K., Greig, N. H., & Counts, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102336 · Cited by 9
Jurasova, V., Andel, R., Katonová, A., Veverová, K., Zuntychová, T., Horáková, H., Vyhnálek, M., Kolářová, T., Maťoška, V., Blennow, K., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01566-w · Cited by 10
Ikanga, J. N., Jean, K. R., Medina, P., Patel, S. S., Schwinne, M., Epenge, E., Gikelekele, G., Tshengele, N., Kavugho, I., Mampunza, S. M. M., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1477047 · Cited by 14
Braudeau, J., Souchet, B., & Streel, E. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100107 · Cited by 11
Kang, J., Son, Y., Yim, Y., Cho, H., Kim, J., Lark, A. R. S., Mir, F. A., Kim, H. J., Park, J., Lee, H., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.022 · Cited by 10
Sin, M., Dage, J. L., Nho, K. T., Dowling, N. M., Seyfried, N. T., Bennett, D. A. A., Levey, A. I., & Ahmed, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041070 · Cited by 9
Novel Blood-Biomarkers to Detect Retinal Neurodegeneration and Inflammation in Diabetic Retinopathy
Hajari, J. N., Ilginis, T., Pedersen, T. T., Lønkvist, C. S., Saunte, J. P., Hofsli, M., Schmidt, D. C., Al-Abaiji, H. A., Ahmed, Y., Bach‐Holm, D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062625 · Cited by 9
Abir, A. R., Dip, S. A., & Zhang, L. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf438 · Cited by 10
Halbgebauer, S., Fazeli, B., Klose, V., Nagel, G., Rosenbohm, A., Rothenbacher, D., Bachhuber, F., Jesse, S., Otto, M., Landwehrmeyer, G. B., et al. (2025) · Clinical Chemistry · doi:10.1093/clinchem/hvaf120 · Cited by 10
Abedin, M. J., & Kastanenka, K. V. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411561 · Cited by 9
JNK inhibitor and ferroptosis modulator as possible therapeutic modalities in Alzheimer disease (AD)
Zakaria, S., Ibrahim, N., Abdo, W., & El‐Sisi, A. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-73596-1 · Cited by 8
Cerebral proteome adaptations to amyloid angiopathy are prevented by carbonic anhydrase inhibitors
Carlsen, J., Fossati, S., Østergaard, L., Gutiérrez‐Jiménez, E., & Palmfeldt, J. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70122 · Cited by 7
Vieiros, M., Almeida-Toledano, L., Serra-Delgado, M., Navarro‐Tapia, E., Ramos-Triguero, A., Muñoz, C., Martínez, L., Marchei, E., Gómez‐Roig, M. D., García‐Algar, Ó., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118138 · Cited by 8
Plasma NfL, GFAP, and pTau181 in patients with isolated REM sleep behavior disorder
Liguori, C., Fernandes, M., Zatti, C., Carpi, M., Tolassi, C., Testone, G., Cirillo, F., Antonucci, M., Bergamo, G., Risino, I., et al. (2025) · SLEEP · doi:10.1093/sleep/zsaf163 · Cited by 11
Yu, Y., Wang, C., Wang, B., Wang, X., Zhao, Q. S., Yan, Y., & Liu, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157271 · Cited by 9
Gunasekaran, T. I., Sanchez, D. L., Reyes‐Dumeyer, D., Ventura, R., Morales, C. D., Alshikho, M. J., Lee, A., Lantigua, R., Gu, Y., Honig, L. S., et al. (2025) · Annals of Neurology · doi:10.1002/ana.70006 · Cited by 8
Zhao, L., Qiu, Q., Zhang, S., Yan, F., & Li, X. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112535 · Cited by 7
Ma, W., Frigon, É., Maranzano, J., Zeighami, Y., & Dadar, M. (2024) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1477973 · Cited by 7
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Osse, A. M. L., Kinney, J. W., & Cummings, J. L. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70050 · Cited by 7
Anita, N. Z., Tarraf, W., Kuwayama, S., Márquez, F., DeCarli, C. S., Thyagarajan, B., Franceschini, N., Lash, J. P., Johns, T. S., González, K. A., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01786-8 · Cited by 9
Zhang, Q., Yu, L.-K., Zhang, X.-Y., Wu, Y., Zhang, H., Wu, J.-L., Yao, Z., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352411 · Cited by 7
Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale
Shafieinouri, M., Hong, S., Lee, P. S., Grant, S. M., Khani, M., Dadu, A., Schuh, A. F. S., Makarious, M. B., Sandon, R., Simmonds, E., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu2937 · Cited by 8
Lu, L., Qin, L., Zhao, X., Liu, Z., Qiu, X., Yang, S., Song, H., & Yang, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1351523 · Cited by 7
Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease
Sintini, I., Singh, N. A., Li, D., Mielke, M. M., Machulda, M. M., Schwarz, C. G., Senjem, M. L., Jack, C. R., Lowe, V. J., Graff‐Radford, J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13713 · Cited by 7
Belinga, L. N., Espourteille, J., Njamnshi, W. Y., Zeukang, A. Z., Rouaud, O., NJAMNSHI, A. K., Allali, G., & Richetin, K. (2024) · Neurodegenerative Diseases · doi:10.1159/000538623 · Cited by 7
Biomarker Identification for Alzheimer’s Disease Using a Multi-Filter Gene Selection Approach
Pashaei, E., Pashaei, E., & Aydın, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051816 · Cited by 8
Wei, Z., Pan, X., Cui, X., Zhang, J., Dai, X., Zeng, Y., & Chen, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1537388 · Cited by 7
“These genes include CLU, CR1 , CD33 , EPHA1 , and TREM2 , which are involved in immunity, and APOE and ABCA7 , which are involved in lipid processing (Kim et al., 2023; Raulin et al., 2022; Zhao et al., 2015).”
Sekimori, T., Fukunaga, K., Finkelstein, D. I., & Kawahata, K. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2310188 · Cited by 7
Metadata
- Authors
- Kim, K. Y., Shin, K. Y., & Chang, K.-A.
- Affiliations
- Gachon University (KR)
- Seoul National University (KR)
- Corresponding author
- Shin, Ki Young
- Chang, Keun-A
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-05-04
- Volume
- 12
- Issue
- 9
- Pages
- 1309
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC10177296
- OpenAlex
- W4376630140
- Cited by
- 309
- References
- 91
- Citations by year
- 2026: 93 · 2025: 126 · 2024: 80 · 2023: 10
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (NRF) (2022R1A2C1092597, 2020R1I1A1A01070793)
- Basic Science Research Program through the NRF of Korea (2022R1A2C1092597, 2020R1I1A1A01070793)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- glial fibrillary acidic protein, Alzheimer's disease, blood biomarkers, peripheral blood, amyloid-beta, mild cognitive impairment, early diagnosis, prognosis, astrocytes
- MeSH terms
- Alzheimer Disease, Glial Fibrillary Acidic Protein, Humans, Biomarkers, Amyloid beta-Peptides, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
